PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 228 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $138,000 | -46.9% | 15,186 | +49.2% | 0.00% | -33.3% |
| Q3 2021 | $260,000 | -49.3% | 10,177 | -33.9% | 0.01% | -45.5% |
| Q1 2021 | $513,000 | +288.6% | 15,394 | -64.3% | 0.01% | +57.1% |
| Q1 2020 | $132,000 | +88.6% | 43,077 | +215.7% | 0.01% | +600.0% |
| Q3 2019 | $70,000 | -91.3% | 13,644 | -89.7% | 0.00% | -92.9% |
| Q2 2019 | $804,000 | -50.4% | 132,929 | -40.7% | 0.01% | -64.1% |
| Q1 2019 | $1,621,000 | +41.2% | 224,300 | +44.6% | 0.04% | +11.4% |
| Q4 2018 | $1,148,000 | +1036.6% | 155,100 | +483.1% | 0.04% | +3400.0% |
| Q4 2016 | $101,000 | -43.9% | 26,600 | +16.2% | 0.00% | -87.5% |
| Q4 2014 | $180,000 | +150.0% | 22,900 | +55.8% | 0.01% | +166.7% |
| Q3 2014 | $72,000 | – | 14,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |